Captor Therapeutics ® Investor Relations

      Investor Relations

      List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 21 February 2022

      Publication date: 2022-02-21
      Number: RB ESPI 8/2022

      Current Report No. 8/2022

      Date of preparation: 21 February 2022

      Subject: List of shareholders holding at least 5% of votes at the Extraordinary General Meeting of the Company on 21 February 2022

      Legal basis: Article 70 point. 3 of the Act on Public Offering and Conditions Governing the Introduction of Financial Instruments to Organized Trading System and of Public Companies dated 29 July 2005

      The Management Board of Captor Therapeutics S.A. with its registered office in Wroclaw (the “Company”) provides the list of shareholders of the Company holding at least 5% of votes at the Extraordinary General Meeting (the “EGM”) of the Company which was held on 21 February 2022:

      1. Michał Walczak held 915,378 shares in the Company, which entitled him to 1,456,395 votes at the EGM, constituting 42.35% of votes at the EGM and 27.61% of the total number of votes;
      2. Paweł Holstinghausen Holsten held 589,966 shares in the Company, which entitled to 950,041 votes at the EGM, constituting 27.63% of votes at the EGM and 18.01% of the total number of votes;
      3. Sylvain Cottens held 340,897 shares in the Company, which entitled to 526,730 votes at the EGM, constituting 15,32% of votes at the EGM and 9.98% of the total number of votes;
      4. Funds Managed by Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.(i.e. Nationale-Nederlanden Dobrowolny Fundusz Emerytalny, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2025, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2030, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2035, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2040, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2050, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2045, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2055, Nationale-Nederlanden Dobrowolny Fundusz Emerytalny Nasze Jutro 2060, Nationale-Nederlanden Otwarty Fundusz Emerytalny) jointly held 328,160 shares in the Company, which entitled to 328,160 votes at the EGM, constituting 9,54% of votes at the EGM and 6.22% of the total number of votes.